Back to All Topics
Research
Research Article
2 min read
When to Discontinue Peptides
Clear criteria for stopping peptide use based on health indicators and symptoms.
Introduction
Knowing when to stop peptide use is critical for maintaining long-term health.
Immediate Discontinuation Criteria
Non-Negotiable Stop Signs
| Sign | Reason | Action |
|---|---|---|
| Severe allergic reaction | Life-threatening | Emergency care |
| Hypoglycemic episode | IGF-1 danger | Stop, glucose |
| Chest pain | Cardiac concern | Stop, medical |
| Severe fluid retention | Excessive effect | Stop, evaluate |
| New lumps/growths | Cancer concern | Stop, evaluate |
Concerning Lab Values
| Finding | Threshold | Response |
|---|---|---|
| IGF-1 >500 ng/mL | Excessive | Stop |
| Fasting glucose >126 | Diabetic range | Stop, evaluate |
| Any rapid change | Significant deviation | Evaluate |
Gradual Discontinuation Indicators
Moderate Concerns
| Indicator | Threshold | Response |
|---|---|---|
| Persistent water retention | Doesn't resolve | Taper off |
| Chronic joint pain | Ongoing | Consider stopping |
| Sleep disruption | Not improving | Reevaluate |
| Numbness/tingling | Carpal tunnel | Reduce/stop |
Lab-Based Decisions
| Finding | Concern Level | Timeline |
|---|---|---|
| IGF-1 400-500 | Elevated | Reduce dose |
| Glucose 100-126 | Pre-diabetic | Lifestyle + reduce |
| Rising HbA1c | Trend concerning | Plan to stop |
Goal-Based Discontinuation
Achieved Objectives
| Situation | Decision | Transition |
|---|---|---|
| Injury healed | Stop healing peptides | Complete cycle |
| Body composition goal | Reassess need | May not need continuation |
| Season completed | Off-season break | Planned cessation |
Diminishing Returns
| Situation | Sign | Response |
|---|---|---|
| Plateau | No further progress | Extended break |
| Tolerance | Reduced response | Cycle off |
| Cost-benefit | Marginal gains | Reevaluate |
Taper Protocols
GH Secretagogues
| Week | Protocol | Notes |
|---|---|---|
| Final 1 | 75% dose | Begin taper |
| Final 2 | 50% dose | Continue reduction |
| End | Discontinue | Complete |
Healing Peptides
| Situation | Protocol |
|---|---|
| Injury resolved | Can stop directly |
| Preventive use | Taper over 1 week |
| Long-term use | Gradual reduction |
Post-Discontinuation Monitoring
Immediate Period (1-2 weeks)
| Monitor | Purpose |
|---|---|
| Symptom resolution | Side effects clearing |
| Energy levels | Adjustment |
| Sleep patterns | Normalization |
Recovery Period (4-6 weeks)
| Monitor | Purpose |
|---|---|
| Blood work | Recovery verification |
| Symptoms | Full resolution |
| Baseline return | System normalization |
Conclusion
Clear discontinuation criteria protect long-term health and enable informed decision-making.
Stay Updated on Peptide Research
Get weekly breakdowns of new studies, dosing insights, and community protocols. No spam, unsubscribe anytime.